The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients
Abstract
Magnetic resonance imaging (MRI) was performed in 20 patients before and after intravenous administration of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) in a dose of 0.1 mmol/kg. Twelve of the patients had clinical and histologic diagnoses of cerebral tumor, six had hepatic tumors, one had hepatic cysts, and one had transitional cell carcinoma of the bladder. Contrast enhancement was seen with all tumors, but not with the hepatic cysts. The degree of enhancement was greater than that seen with computed tomography (CT) in 13 cases, equal to it in six, and less in one. Contrast enhancement was detectable as long as 18 hr after injection of Gd-DTPA in one case of cerebral tumor. The margin between cerebral tumor and peritumoral edema could be delineated with contrast-enhanced MRI to the degree possible with contrast-enhanced CT. In the liver isointense enhancement was seen with saturation-recovery (SR), inversion-recovery (IR), and spin-echo (SE) sequences although not with all three sequences simultaneously. In general IR sequences were most sensitive for display of the contrast agent, but the enhancement often decreased the difference between abnormal and normal tissue. No short-term side effects were encountered and no significant change was seen in urea, creatinine, electrolytes, liver function tests, blood coagulation, or urine testing after injection of Gd-DTPA. Although much more work will be required to evaluate this contrast agent, these initial experiences are very promising.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
Weinmann, H., Brasch, R., Press, W., & Wesbey, G. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.142.3.619 · Cited by 1,231
Self-citationClinical NMR imaging of the brain: 140 cases
Bydder, G., Steiner, R., Young, I., Hall, A., Thomas, D., Marshall, J., Pallis, C., & Legg, N. (1982) · American Journal of Roentgenology · doi:10.2214/ajr.139.2.215 · Cited by 401
Self-citationNuclear Magnetic Resonance (NMR) Imaging of Tumors in the Posterior Fossa
McGinnis, B. D., Brady, T. J., New, P. F. J., Buonanno, F. S., Pykett, I. L., DeLaPaz, R. L., Kistler, J. P., & Taveras, J. M. (1983) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198308000-00001 · Cited by 80
Cited by
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
Weinmann, H., Brasch, R., Press, W., & Wesbey, G. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.142.3.619 · Cited by 1,231
Self-citationBiological Applications of Rare-Earth Based Nanoparticles
Bouzigues, C., Gacoin, T., & Alexandrou, A. (2011) · ACS Nano · doi:10.1021/nn202378b · Cited by 598
Intravascular susceptibility contrast mechanisms in tissues
Kennan, R. P., Zhong, J., & Gore, J. C. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310103 · Cited by 524
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
Lohrke, J., Frenzel, T., Endrikat, J., Alves, F. C., Grist, T. M., Law, M., Lee, J. M., Leiner, T., Li, K.-C., Nikolaou, K., et al. (2016) · Advances in Therapy · doi:10.1007/s12325-015-0275-4 · Cited by 420
Metadata
- Authors
- Carr, D., Brown, J., Bydder, G., Steiner, R., Weinmann, H., Speck, U., Hall, A., & Young, I.
- Venue
- American Journal of Roentgenology
- Publisher
- American Roentgen Ray Society
- Published
- 1984-08-01
- Volume
- 143
- Issue
- 2
- Pages
- 215-224
- ISSN
- 0002-9580 (ISSN-L)
- 0361-803X
- 1546-3141
- OpenAlex
- W1978084209
- Cited by
- 299
- References
- 3
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. https://app.cochat.ai/papers/10.2214/ajr.143.2.215
- The paper
- Carr, D., Brown, J., Bydder, G., Steiner, R., Weinmann, H., Speck, U., Hall, A., & Young, I. (1984). Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. American Journal of Roentgenology. https://doi.org/10.2214/ajr.143.2.215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.